Yang Yu-Xian, Li Lin, Wang Gangyu, Jiang Xiaobo, Li Hua, Jia Le-Cheng, Zhou Guanqun, Sun Ying
Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, CHN.
Real-time Laboratory, Shenzhen United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, CHN.
Cureus. 2024 Sep 12;16(9):e69262. doi: 10.7759/cureus.69262. eCollection 2024 Sep.
Intensity-modulated radiation therapy (IMRT) improves tumor control and reduces long-term radiation-induced complications of patients with nasopharyngeal carcinoma (NPC), contingent upon accurate contouring and precise delivery of treatment plans. Online adaptive radiotherapy (ART) involves real-time treatment plan modification based on the variations in targets and organs at risk (OARs) to uphold treatment planning accuracy. This study describes the first reported case of fan beam computed tomography (FBCT)-guided online ART for NPC using a novel integrated platform. Online ART was performed at the 25th fraction in this case, as tumors and the patient's anatomy were observed to regress inter-fractionally, necessitating adjustments to the contours based on the anatomy of the day. Online ART plan optimized target volume coverage while reducing doses to OARs. Notably, online ART significantly improved radiotherapy efficiency. This patient achieved a clinical complete response 12 weeks post-treatment, with Epstein-Barr virus DNA levels reduced to 0 copies/ml. Currently, the patient is alive without evidence of high-grade toxicity or local recurrence at approximately 10 months post-treatment. This case confirms the feasibility and dosimetric benefit of online ART for NPC using a novel integrated platform. Further research is needed to confirm its clinical benefits.
调强放射治疗(IMRT)可改善鼻咽癌(NPC)患者的肿瘤控制并减少长期放疗引起的并发症,这取决于精确的轮廓勾画和治疗计划的精确实施。在线自适应放疗(ART)涉及根据靶区和危及器官(OARs)的变化实时修改治疗计划,以维持治疗计划的准确性。本研究描述了首例使用新型集成平台的扇束计算机断层扫描(FBCT)引导的鼻咽癌在线ART病例。在该病例中,第25次分割时进行了在线ART,因为观察到肿瘤和患者解剖结构在分次间有所退缩,需要根据当日解剖结构调整轮廓。在线ART计划优化了靶区体积覆盖,同时降低了对OARs的剂量。值得注意的是,在线ART显著提高了放疗效率。该患者在治疗后12周达到临床完全缓解,EB病毒DNA水平降至0拷贝/ml。目前,患者在治疗后约10个月存活,无高级别毒性或局部复发迹象。该病例证实了使用新型集成平台对鼻咽癌进行在线ART的可行性和剂量学益处。需要进一步研究以证实其临床益处。